Cytokine: X : Impact Factor & More
eISSN: 2590-1532
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Cytokine: X
Cytokine: X Journal Specifications
Indexed in the following public directories
Scopus 
SJR
| Overview | |
| Publisher | Elsevier |
| Language | English |
| Article Processing Charges | USD 2000 |
| Publication Time | 15 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Cytokine: X ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cytokine: X
Editorial Board
- 1 Jun 2022
- Cytokine: X
Progress of exosome research in systemic lupus erythematosus
- 21 May 2022
- Cytokine: X
Editorial Board
- 1 Mar 2022
- Cytokine: X
Plasminogen activator inhibitor-1 mediate downregulation of adiponectin in type 2 diabetes patients with metabolic syndrome
- 22 Jan 2022
- Cytokine: X
TNFAIP8 modulates the survival and immune activity of Th17 cells via p53/ p21/ MDM2 pathway after acute insult
- 18 Jan 2022
- Cytokine: X
An exploratory study of circulating cytokines and chemokines in patients with muscle disorders proposes CD40L and CCL5 represent general disease markers while CXCL10 differentiates between patients with an autoimmune myositis
- 18 Jan 2022
- Cytokine: X
Editorial Board
- 1 Jun 2022
- Cytokine: X
Progress of exosome research in systemic lupus erythematosus
- 21 May 2022
- Cytokine: X
Editorial Board
- 1 Mar 2022
- Cytokine: X
Plasminogen activator inhibitor-1 mediate downregulation of adiponectin in type 2 diabetes patients with metabolic syndrome
- 22 Jan 2022
- Cytokine: X
TNFAIP8 modulates the survival and immune activity of Th17 cells via p53/ p21/ MDM2 pathway after acute insult
- 18 Jan 2022
- Cytokine: X
An exploratory study of circulating cytokines and chemokines in patients with muscle disorders proposes CD40L and CCL5 represent general disease markers while CXCL10 differentiates between patients with an autoimmune myositis
- 18 Jan 2022
- Cytokine: X
FAQs on Cytokine: X
How many articles did Cytokine: X publish last year? 
Who is the publisher of Cytokine: X?
